The Analyst · 2016 · 18 citations · 12 references
Life SciencesChemical BiologyMolecular BiologyProteomicsClinical BiosensingNanomedicineProtein QuantificationQuantum DotsQuantum Dots In BiologyBioimagingBiomolecular DetectionQuantum Dot Fluorescence
We report the development and application of an analytical system consisting of capillary electrophoresis (CE) interfaced with inductively coupled plasma mass spectrometry (ICP-MS) for sensitive and high-resolution characterization of quantum dots (QDs) interacting with serum proteins. Separation resolution between the intact CdSeS/ZnS QDs and their protein conjugates was optimized by varying the type and concentration of background electrolyte, applied voltage, and sample loading. Special attention was paid to the CE system compatibility with physiological conditions, avoiding aggregation effects, and analyte recovery. Optimization trials allowed for acquiring satisfactory stability of migration times (within 6.0% between different days), peak area precision of 5.2-8.0%, capillary recoveries in the range of 90-96%, and a lower limit of detection of 7.5 × 10(-9) mol L(-1) Cd. With the developed method distinct metal-specific profiles were obtained for the QDs in combination with individual serum proteins, their mixtures, and in human serum. Particularly, it was found that albumin binding to the particle surface is completed after 1 h, without noticeable disruption of the core-shell integrity. The transferrin adsorption is accompanied by the removal of the ZnS shell, resulting in evolving two different metal-protein conjugated forms. On the other hand, proteinization in real-serum environment occurs without binding to major transport proteins, the QDs also lose their the shell (the higher the dose the longer is the time they stay unbroken). The concomitant changes in migration behavior can be attributed to interactions with serum proteins other than albumin and transferrin. Speciation information provided by CE-ICP-MS may shed light on the mechanism of QD delivery to the target regions of the body.
12
Time Evolution of the Nanoparticle Protein Corona
Eudald Casals, Tobias Pfaller, Albert Duschl et al. · ACS Nano · 2010 · 1.2K citations
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Martin Lundqvist, Johannes Stigler, Tommy Cedervall et al. · ACS Nano · 2011 · 788 citations
Pharmacy, Biochemistry, Biophysics +17
Bio-distribution and metabolic paths of silica coated CdSeS quantum dots
Zhen Chen, Chen Hu, Huan Meng et al. · Toxicology and Applied Pharmacology · 2008 · 154 citations